Improved Prostate Cancer Survival Rates with Hormone Therapy and Current Treatments – News Update
Prostate cancer is the second most common cancer in men, after skin cancer. According to the American Cancer Society, there will be an estimated 248,000 new cases of prostate cancer and 34,000 deaths from prostate cancer in the United States in 2021.
The good news is that prostate cancer survival rates have significantly improved over the past few years due to advancements in hormone therapy and other treatments. In this blog post, we will discuss the latest news updates on prostate cancer survival rates and the treatments that have contributed to this improvement.
Hormone Therapy and Prostate Cancer
Hormone therapy, also called androgen deprivation therapy (ADT), is a common treatment for advanced prostate cancer. It works by lowering the level of androgen hormones in the body, which prostate cancer cells need to grow. This treatment can be used on its own or in combination with other treatments, such as radiation therapy.
A recent study published in the New England Journal of Medicine found that men with advanced prostate cancer who received hormone therapy lived longer than those who received a placebo. The study involved over 1,800 participants from 12 countries and showed that the use of hormone therapy reduced the risk of death by 34%.
This study confirms the effectiveness of hormone therapy in advanced prostate cancer and highlights the need for more research to improve treatment outcomes for prostate cancer patients.
Current Treatments for Prostate Cancer
In addition to hormone therapy, there are several other treatments available for prostate cancer, depending on the stage and severity of the cancer. These treatments include:
– Surgery: Prostatectomy is a surgical procedure that removes the prostate gland and the surrounding lymph nodes. This is a common treatment for early-stage prostate cancer.
– Radiation therapy: This treatment uses high-energy X-rays or other types of radiation to kill cancer cells. It can be used alone or in combination with other treatments.
– Chemotherapy: This treatment uses drugs to kill cancer cells. It is usually used for advanced prostate cancer that has spread to other parts of the body.
– Immunotherapy: This treatment uses the body’s own immune system to fight cancer cells. It is a newer treatment that is still being studied.
Advancements in these treatments have contributed to the improved survival rates of prostate cancer patients.
Summary
Prostate cancer survival rates have significantly improved over the past few years due to advancements in hormone therapy and other treatments. A recent study has shown that hormone therapy can reduce the risk of death by 34% in advanced prostate cancer patients. There are several other treatments available for prostate cancer, including surgery, radiation therapy, chemotherapy, and immunotherapy. These treatments have contributed to the improved survival rates of prostate cancer patients. It is important for patients to work closely with their doctors to determine the best treatment plan for their individual case.
Hashtags: #prostatecancer #hormonetherapy #survivalrates #cancerresearch #medicaladvancements #BUSINESS